Member Info for Chan

Some expected profit taking from last Friday's rise, no suprise. However, still buying interest yesterday and this morning, the SP is holding up @ 12.75p

Now at its lowest SP for some time, and due to several shortfalls of expectations over the last two years. Delling which has a good product and if things go well and to plan this is a Speculative Buy in my book, and not without risk if the market tightens. At 7p Delling is capitalised at £11.6 million. It trades on a calendar 2007 multiple of 10.6 falling to just 2.9 times 2008 forecast earnings. The price to sales ratio is just 0.53 for 2007 falling to 0.33 for 2008. The business is profitable at present and there are no balance sheet constraints on growth. The share price discounts historic underperformance at a trading level but allows nothing for the clear recovery potential. We believe that if Delling achieves its forecasts for this year and next then it would merit a mid-teens rating and that implies a target price of 35p. Shareholders There are currently 166,016,147 shares in issue. Those holding more than 3% of the issued share capital are: Bjart Dysthe 24.47% RAB Capital 12.71% Geir Lolleng 10.78% Tine Pension Fund 7.98% Aksel Bratvedt 3.81%

Cantor Fitzgerald Europe Holding http://www.investegate.co.uk/Article.aspx?id=200706250948009353Y

Hi steviedee, glad you caught my call, seemed lots of interest through the day, in a more difficult Market of late. As for GED, haven't checked this out as yet and need more time, but notice the SP much lower and recent Chairman and Director Buying stock. Always a good sign. Best Wishes!

25 May James J. Padilla 160.000 @ 30.80p 21 June " " 110.000 @ 31.95P 24 May Scott T. Harrisson 80.000 @ 31.43p Probably purchased in Canadian Dollars on the Canadian Exchange In my book this is a good sign to join tham.

amsh - on Friday I would of said YES and I did @ 09.35am I am sure the LNR SP will rise as per the recent increased valuation. How quick, I cannot answer. This is for the crystal ball reader. However, it's cheap at present so you must decide. I bought a small batch last November @ 12'ish p and they went to 14p., the share is now much better placed for longer term growth. But worth a shorter term punt I would of thought! Good Luck!

Friday's Stockmarket Report. A stunning set of full year numbers lifted the shares of Libra Natural Resources* (LNR) by 3p to 14p. The company recorded a steep increase in its full-year profits, adding that it was still in exclusive talks to buy an unnamed major UK pellet maker with some form of conclusion expected imminently. Pre-tax profits of 2.55 million pounds equated to earnings of 1.16p per share and a complete turnaround from a loss a year earlier. Research outfit GE&CR responded by increasing its target price to 32p from 18p.

SparkyA1 Read your message, good you were there, so beautiful and a real contrast to here! RE: HLO the website below is for the Company. The Main Shareholder and Chief Executive Kate Bleasedale is a clever Lady. Search....... HCL plc | Healthcare Recruitment | Doctors Jobs | AHP Jobs | HSS ..... HCL is the new name for Healthcare Locums plc ... 2 November 2006 - Healthcare Locums plc - Blue... www.hclplc.com/ Have a good weekend!

Hi sparkyA1, thank you for your reply. Was near Guangzhou in the south. A small Industrial estate which is surrounded by cultivated area, dense green and the best Cantonese food. Sadly only there for two nights. The link you mention is it for HLO?

It's on a role and may make 13p by the afternoon, if there aren't too many DT's on the rack. It's cheap at present and a longer term buy.

Valuation from UK.Analyst.com At 11.5p, Libra is valued at £18.61 million which values the stock on a 2006 Price Earnings multiple of 10 – well below the renewable energy sector’s range of 15-20. A 15 times 2007 price earnings multiple would value Libra at around 32p. Based on conservative estimates (table 1 below) we forecast a 2007 turnover figure from Libra’s wood pellet operations of £8.20 million, a pre-tax profit of £3.50 million and an earnings per share of 2.03p on a fully diluted basis for calendar 2007. This leaves the shares on a current year price earnings multiple of 5.25 which hardly represents the growth story and potential for this fast developing company. The upside potential for this stock is strong given the significant investment the company has made in waste gas and coal, whilst re-positioning itself to focus primarily in the fast growing wood pellets business, through the Emerald Bio-Energy vehicle. Given that the biofuels, solar, wind, and other renewable energy stocks have a 2007 PE multiple range from 14-34, we consider our target case valuation of Libra at 32 pence a conservative and prudent number. We revise upwards our target valuation of Libra from 18p to 32p. At 11.5p our stance remains buy.

Friday, 22nd June 2007 08:02 Libra Natural Resources FY pretax soars; still in talks to buy UK pellet maker LONDON (Thomson Financial) - Libra Natural Resources PLC posted a steep increase in its full-year profit, and said it is still in exclusive talks to buy an unnamed major UK pellet maker with 'some form of conclusion expected imminently'. The cleaner fuel company said that, as a consequence of its evolution into a focused wood pellet manufacturing group, it intends to put all its non-pellet investments into a separate holding company. Libra reported a pretax profit of 2.55 mln stg for the year to Dec 31 on first sales of 2.36 mln, compared with a 156,000 stg profit a year earlier. Libra said it believes its wood pellet operations represent an extraordinary business opportunity. Initial unaudited indications for the first quarter of 2007, with record pellet production and revenues, strengthen this belief, it added. 'We look forward with real confidence to the coming year,' said chief executive Peter Greensmith.

First Artist is currently trading in line with management expectations and is optimistic for continued growth for the remainder of the year and beyond and looks like the MMs are raising the SP on early buys this am. The spread is currently @ 2.5p and looks like the share is on a roll. Also fancied by our friend Tom.

Looking at the 5 year Graph, the SP slope is one of steady growth moving from circa 200p to circa 775p at the start of 2007, Then dropping down and now at 594.50p. The Director Buys may suggest an upturn on further good news and figures. Maybe one for dasv. A very interesing portfolio!

Hi sparkyA1, I hope all is well with you and that you're hanging in with RCG. It has been a strange few weeks and I cannot go into too much detail, it would take ages. Been to Sweden and a quick trip to China to visit an engineering company, where a friend is setting up a partnership with a Chinese engineering company. Nice people with a fantastic outlook and many of them are concerned about China's Carbon footprint. So, time will tell. Who are we to judge looking back! It was interesting that the folks we met knew about RCG and their products. There is a massive market here as you can imagine and RCG are through the door. As you know they are currently at Securex in Jo'burg SA that will bring in revenue for sure. Setting aside the previous hitch I am convinced RCG is well underpriced. I am hanging in. PS Take a look at HLO and check out their website, it looks like a sure bet and Barclays and many others setting a stake. SEE: http://www.hclplc.com/

Wednesday, 20th June 2007 08:23 LiDCO says US patent granted for cardiac pacemaker adjustment method, device LONDON (Thomson Financial) - LiDCO Group PLC , the AIM-quoted cardiovascular monitoring company, said it has received the US patent for a new method and apparatus for optimally adjusting a biventricular pacemaker used in the treatment of congestive heart failure (CHF). The technology, which is predominantly for the treatment of intensive care and anaesthesia patients, has seen a number of 'influential' university hospitals field trialing it, in order to improve the response of CHF patients with implantable biventricular pacemakers, the UK-based LiDCO added. 'Although this is still somewhat early days, the grant of additional intellectual property in this arena means that if the results of these trials prove positive, we should have a strong and protectable market position,' chief executive Terry O'Brien said. TFN.newsdesk@thomson.com

Thursday, 21st June 2007 07:40 LiDCO says 1st 4 months sales up 61 pct; on track to meet expectations LONDON (Thomson Financial) - Cardiovascular monitoring company LiDCO Group PLC said sales in the first four months to May 31 were up 61 pct over the corresponding year-ago period, driven by a shortening of the monitor sales cycle during the period. The company added that it is on track to achieving its expectations. 'Increased revenues have been achieved in all territories - with particularly marked growth seen in Europe,' chief executive Terry O'Brien said in an AGM statement. LiDCO said its margins, excluding leasing arrangements, have been maintained and administration expenses are well controlled and within the company's budgets. TFN.newsdesk@thomson.com

** Clapham House (CPH.L: Quote, Profile , Research) Group is thought to be in talks with potential franchise partners in Turkey about expanding its Gourmet Burger Kitchen (GBK) brand, The Times reported. The AIM-listed restaurant operator, which has 27 GBKs in the United Kingdom, is also about to enter the Irish Republic, it said.

Did you read the news last week? http://www.rcg.tv/press/business/120607.html Article of interest on Frost & Sullivan web. See: http://www.frost.com/prod/servlet/exec-brief-movers-feature.pag?mode=open&sid=99188968

Just topped up for the third time with profits from HCL quite prepared to just sit and wait. The SP IS CHEAP!